Mariam Alexander

133 posts

Mariam Alexander

Mariam Alexander

@MariamAlex26

Thoracic Med Onc @MUSChealth @muschollings Charleston, South Carolina. Former Heme/Onc fellow @MontefioreNYC @EinsteinMed

Katılım Haziran 2019
394 Takip Edilen292 Takipçiler
Mariam Alexander retweetledi
@·
Lots of discussion about the future landscape for SCLC at the IS Focus Meeting on Lung Cancer with great talks by Drs. @alissajcooper @HosseinBorghaei @MariamAlex26 @dominicandoc2 - where will ADCs end up making the biggest contribution?
tweet media tweet media tweet media tweet media
English
1
4
17
1.5K
Mariam Alexander retweetledi
Balazs Halmos
Balazs Halmos@BalazsHalmosMD·
Congrats on a first US Focus Meeting on Lung Cancer where @CharuAggarwalMD and @StephenVLiu got just the right pieces together to build a great event- including a Monte mini-reunion in Honky-Tonk town @Shuai_WangOnc @HyeinJeon_MD
Balazs Halmos tweet mediaBalazs Halmos tweet mediaBalazs Halmos tweet mediaBalazs Halmos tweet media
@

Inaugural US Focus Meeting on Lung Cancer from @_MDEducation starts in Nashville with EGFR session. Great overviews by Drs. @LeXiuning Liza Villaruz @ZPiotrowskaMDand panel chaired by @CharuAggarwalMD. Great areas for discussion including LCT, bispecifics, and ADCs.

English
2
7
39
3.3K
Mariam Alexander retweetledi
@·
Honored to share this @ASCO Connect piece on my career journey 🙏 Grateful to @CliffordHudis for highlighting it 🙌 Wonderful 10+ years of growth, networking, and friendships ✨ More to come. "Where You Start Does Not Define Where You Can Go”: Dr. Abirami Sivapiragasam’s Journey and Reflections for Early-Career Oncologists | ASCO Connection connection.asco.org/do/you-start-d…
English
3
8
44
2K
Mariam Alexander retweetledi
@·
FDA approves subcutaneous amivantamab - finally! This is a no-brainer switch in my opinion. Faster, decrease risk of infusion reaction, less risk of VTE. Even possibility of greater efficacy versus IV (needs confirmation). Will switch as soon as we can. jnj.com/media-center/p…
English
2
37
138
7.6K
Mariam Alexander retweetledi
@·
.@anguspratt was a giant in the lung cancer community. An advocate, friend, and warm, unforgettable presence. His legacy lives on in the research and advocacy he championed. We feel the weight of his loss, and we’ll continue the work that meant so much to him.
English
0
14
34
4.1K
Mariam Alexander retweetledi
@·
#DCLung25 Hard-hitting talk on biomarker testing in NSCLC by @christine_lovly, where she highlights: - expanding list of targeted therapy - cannot prescribe, if test is not done - interpreting lung cancer genomic results has become an ‘in the weeds’ skill Wow @IASLC #LCSM
tweet media tweet media tweet media tweet media
English
2
8
22
1.6K
Mariam Alexander retweetledi
@·
Quick pre #DCLung25 visit to the National Portrait Gallery @smithsoniannpg - my favorite museum in DC - with some of the faculty!
tweet media tweet media tweet media tweet media
English
0
5
43
2.2K
Mariam Alexander retweetledi
@·
Wow. Dr. @DrJNaidoo gives the #DCLung audience a true master class on immune related toxicities, debunking myths & providing pearls on long-term management. Steroids are not always the preferred initial treatment. Rechallenge possible. Specific irAEs have different prognosis.
tweet media tweet media tweet media tweet media
English
0
16
51
3.2K
Mariam Alexander retweetledi
@·
#DCLung25 My fellow 🇪🇺 speaker at DCLung @Alfdoc2 comprehensively reviews bispecifics, & where they are going in NSCLC. Applications are broad, to: - IO-responsive tumors (eg Ivonescimab) - Oncogene+ tumors (eg izi-bren, EGFR) - the future: bicycles & more! @IASLC @hug_ge #LCSM
tweet media tweet media tweet media tweet media
English
2
11
37
2.9K
Mariam Alexander
Mariam Alexander@MariamAlex26·
You are our inspiration @BalazsHalmosMD . Also I have not figured out how you manage to be so funny while being educational. It’s an art!
@

@HyeinJeon_MD @Joshua_Reuss @StephenVLiu Great to see you, Hyein and also other amazing Monte grad @MariamAlex26 at #DCLung25 today! It is truly just a special thrill to witness our prior mentees succeeding- wonderful to learn about you taking a fantastic start w @StephenVLiu at MedStar Washington Hospital Center!

English
0
0
6
650
Mariam Alexander retweetledi
@·
Dr. @MariamAlex26 with a comprehensive overview of the symphony of emerging ADCs in lung cancer. Lots of emerging data and smattering of approvals, but ideal biomarkers still needed. #DCLung25
tweet media tweet media tweet media
English
0
4
9
822
Mariam Alexander retweetledi
@·
Beautiful tour of antibody drug conjugates from Dr. @MariamAlex26 at #DCLung25 with new approvals of datopotamab deruxtecan in EGFR mutant NSCLC and telisotuzumab vedotin in MET IHC+ NSCLC. Biomarker development critical to optimal use (NMR QCS) and new classes of ADCs coming!
tweet media tweet media tweet media tweet media
English
0
15
49
5.2K
Triparna Sen (Sen-Lab)
Triparna Sen (Sen-Lab)@triparnasen·
Professor with Tenure! So thankful for my mentors, colleagues, & collaborators who made this milestone possible! Nothing but deep gratitude to the amazing trainees, past & present, who made the science & the journey meaningful. Excited for what lies ahead, here is to the future... @OSUCCC_James @OhioStateMedOnc @OSUWexMed @OhioStateWIMS @OhioStatePIIO @OncLive @OncoAlert @oncodaily #LCSM #WomeninAcademia #WomeninSTEM #SCLC #NSCLC #lungcancer
English
11
1
69
5.2K
Mariam Alexander retweetledi
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiu·
Don't miss #DCLung25 - a one-day, @IASLC endorsed comprehensive lung cancer conference on Saturday, October 4th in Washington DC. Joining us will be Dr. Mariam Alexander @MariamAlex26, who will outline antibody drug conjugates (ADCs) in lung cancer. medstarhealth.org/dclung25
Stephen V Liu, MD tweet media
English
0
2
13
1.4K
Mariam Alexander
Mariam Alexander@MariamAlex26·
Such a treat to discuss this important approval and learn about the history of Sunvozertinib development and trial design and nuances of dose/toxicities from Dr James Yang. Thanks @StephenVLiu @IASLC #lcsm @EGFRResisters
@

Watch for this episode of the @IASLC podcast Lung Cancer Considered next week - I discuss the latest FDA approval for lung cancer: sunvozertinib, for lung cancer with an EGFR exon 20 insertion. Great discussion and background with Drs. James Chih-Hsin Yang and @MariamAlex26!

English
2
1
11
960
Balazs Halmos
Balazs Halmos@BalazsHalmosMD·
Really imp Q w multiple ex20ins targeting drugs likely available soon But we will need to unzip a lot of new data as to acq resistance/matching drugs to know… While these 2 drugs + firmomertinib look like triplets on paper, maybe there are subtle differences as to activity against different mutants We need to keep habit of mol retesting upon progression to be able to learn sciencedirect.com/science/articl…
Balazs Halmos tweet mediaBalazs Halmos tweet media
GIF
English
1
0
8
304

Keşfet

@alissajcooper @HosseinBorghaei @dominicandoc2 @BalazsHalmosMD @CharuAggarwalMD @StephenVLiu @Shuai_WangOnc @HyeinJeon_MD